Security key
03763A207
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 32,123,424
- Total 13F value
- $1,489,347,761
- Share change
- +2,123,944
- Put/Call ratio
- 33%
- SEC-reported price per share
- $46.41
- Number of holders
- 207
- Value change
- +$104,542,594
- Number of buys
- 134
- Number of sells
- 66
- Shares outstanding
- 49,605,599
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
207
Top holders
10
ASTH full security history
Ownership snapshot
Full 13F holder table
Astrana Health, Inc. SEC filings
Astrana Health, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ASTH - Astrana Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
ALLIED PHYSICIANS OF CALI...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
12%
ALLIED PHYSICIANS OF CALIFORNIA, ...
11%
VANGUARD PORTFOLIO MANAGEMENT LLC
5.3%
Thomas S. Lam
16%
Kenneth T. Sim
16%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
12%
|
$191,646,870
6,234,446 shares
|
-$6,109,882 | 31 Mar 2025 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp |
3/4/5
13D/G
10%+ Owner · Allied Physicians of California, a Professional Medical Corporation
|
11%
from 13D/G
|
$232,801,164
6,132,802 shares
|
— | 15 Feb 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
5.3%
|
$126,195,454
2,648,939 shares
|
$0 | 30 Jun 2026 |
| Thomas S. Lam |
3/4/5
Director
|
16%
|
$189,593,458
7,732,165 shares
|
— | 06 Apr 2026 |
| Kenneth T. Sim |
3/4/5
Executive Chairman, Director
|
16%
|
$188,614,541
7,692,242 shares
|
— | 06 Apr 2026 |
| Brandon Sim |
3/4/5
CEO and President
|
3.8%
|
$46,512,771
1,896,932 shares
|
— | 27 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
207
Shares
32,123,424
Rows available
207
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
170
Q2 2026 holders
207
Holder diff
37
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|